BioLine RX Stock

BioLine RX Cash Flow per Share

The Operating Cash Flow per Share of BioLine RX (BLRX.TA) as of Sep 2, 2026 is -0.04 USD. In the previous year, Operating Cash Flow per Share was -0.02 USD — a change of 56.04% (lower).

Cash Flow per Share

-0.04USD

YoY

56.04%

Last updated:

Operating Cash Flow per Share of BioLine RX is 2026 -0.04 USD. Operating Cash Flow per Share of BioLine RX was 2025 -0.02 USD. It decreases by 56.04% lower compared to the previous year.

The BioLine RX Cash Flow per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Flow per Share
Date
Cash Flow per Share
Jan 1, 2017
-0.23 USD
Jan 1, 2018
-0.22 USD
Jan 1, 2019
-0.15 USD
Jan 1, 2020
-0.09 USD
Jan 1, 2021
-0.04 USD
Jan 1, 2022
-0.03 USD
Jan 1, 2023
-0.02 USD
Jan 1, 2024
-0.04 USD
The BioLine RX Cash Flow per Share history
YEARCash Flow per ShareYoY
-0.04USD+56.04%
-0.02USD-30.78%
-0.03USD-4.65%
-0.04USD-61.26%
-0.09USD-40.72%
-0.15USD-30.50%
-0.22USD-2.45%
-0.23USD-11.65%
-0.26USD-6.21%
-0.28USD-43.25%
-0.49USD—
Access this data via the Eulerpool API
Get Free API Key

BioLine RX Stock analysis

What does BioLine RX do? BioLine RX Ltd is a global biopharmaceutical company specializing in the development of novel therapies for cancer and other serious diseases. The company is headquartered in Israel and has offices in the United States and Europe. BioLine RX is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BioLine RX stock

Operating Cash Flow per Share of BioLine RX is -0.04 USD in 2026.

Operating Cash Flow per Share of BioLine RX changed from -0.02 USD to -0.04 USD, representing a 56.04% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow per Share BioLine RX since 2006 – with annual values, charts, and detailed analysis.

Operating cash flow per share measures the operating cash generated per outstanding share.

Access this data via the Eulerpool API
Get Free API Key

Cash Flow — BioLine RX

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — BioLine RX